Tissue-specific effects of valsartan on rstn and fiaf gene expression in the ob/ob mouse.

about

Angiopoietin-like protein 4: health effects, modulating agents and structure-function relationships Metreleptin therapy lowers plasma angiopoietin-like protein 3 in patients with generalized lipodystrophy.A review of the multifunctionality of angiopoietin-like 4 in eye disease

P2860

Q28263229-3120DFE3-F21F-4519-AC76-E0CA49CB4BB3 Q51002875-BDD1660A-1368-4AFC-9C9A-30EA5B0C4C8C Q57157493-0A4B48CE-5602-4798-B35F-B1666EA3EF87

P2860

Tissue-specific effects of valsartan on rstn and fiaf gene expression in the ob/ob mouse.

Item

http://www.wikidata.org/entity/Q38343977

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Tissue-specific effects of valsartan on rstn and fiaf gene expression in the ob/ob mouse.

@en

type

Item

label

Tissue-specific effects of valsartan on rstn and fiaf gene expression in the ob/ob mouse.

@en

prefLabel

Tissue-specific effects of valsartan on rstn and fiaf gene expression in the ob/ob mouse.

@en

P1476

Tissue-specific effects of valsartan on rstn and fiaf gene expression in the ob/ob mouse.

@en

P2093

M Wilkinson

http://www.w3.org/2001/XMLSchema#string

R E Brown

http://www.w3.org/2001/XMLSchema#string

S A Imran

http://www.w3.org/2001/XMLSchema#string

P2860

Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice

Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation

Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene

Differential regulation and properties of angiopoietin-like proteins 3 and 4

Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists.

Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting.

Adipokines: inflammation and the pleiotropic role of white adipose tissue.

Gene expression in visceral and subcutaneous adipose tissues.

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial.

P304

231-238

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1479164110369848

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44601810

http://www.w3.org/2001/XMLSchema#string

P698

20472602

http://www.w3.org/2001/XMLSchema#string

Tissue-specific effects of valsartan on rstn and fiaf gene expression in the ob/ob mouse.

about

P2860

P2860

Tissue-specific effects of valsartan on rstn and fiaf gene expression in the ob/ob mouse.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698